| abstract |
The present application relates to new benzimidazole derivatives and, of imidazopyridine of general formula (1) which have a good affinity for some subtypes of melanocortin receptors, particularly receptors MC4. They are particularly useful for treating disease states and diseases in which one or more melanocortin receptors are involved. The invention also relates to pharmaceutical compositions containing said products. (see formula 1) |